Applied DNA Sciences Inc Stock OTC Bulletin Board
Equities
US03815U1025
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 5.22M 7.11M | Sales 2025 * | 7.39M 10.06M | Capitalization | 2.55M 3.48M |
---|---|---|---|---|---|
Net income 2024 * | -12M -16.34M | Net income 2025 * | -13M -17.7M | EV / Sales 2024 * | 0.49 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.35 x |
P/E ratio 2024 * |
-0.28
x | P/E ratio 2025 * |
-0.29
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 101.62% |
Latest transcript on Applied DNA Sciences Inc
Managers | Title | Age | Since |
---|---|---|---|
James Hayward
CEO | Chief Executive Officer | 71 | 05-09-27 |
Beth Jantzen
DFI | Director of Finance/CFO | 47 | 13-04-30 |
Lawrence Jung
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yacov Shamash
BRD | Director/Board Member | 74 | 06-03-16 |
Bob Catell
BRD | Director/Board Member | 87 | 16-10-06 |
James Hayward
CEO | Chief Executive Officer | 71 | 05-09-27 |
1st Jan change | Capi. | |
---|---|---|
-4.57% | 12.32B | |
-4.35% | 8.1B | |
+8.91% | 5.87B | |
+30.81% | 5.52B | |
-7.42% | 4.29B | |
-54.27% | 3.16B | |
+14.44% | 2.72B | |
-2.21% | 2.37B | |
+28.53% | 2.23B |